Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy (EPZSwitch)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2012 by Therapeutic Concepts.
Recruitment status was:  Recruiting
Sponsor:
Information provided by (Responsible Party):
Therapeutic Concepts
ClinicalTrials.gov Identifier:
NCT01608269
First received: May 25, 2012
Last updated: May 29, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)